PhD Chemist and formulation leader with 20+ years in pharma R&D, specializing in LNP delivery systems to translate mRNA, siRNA, and DNA candidates into preclinical pipelines.
Dr. Ann-Kathrin Bernert is Head of Production. She is responsible for ATMP production, driving GMP process development, and the advancement of innovative cell and gene therapies. She brings more than…
Dr. Niklas Beschorner is Chief Technology Officer (CTO) and co-founder of PROVIREX. He is responsible for ATMP manufacturing and R&D, driving the development of enabling technologies, translational processes, and novel…
Dr. Maike Voges is a co-founder of PROVIREX. She has been part of the team since 2013 and was closely involved in planning, construction oversight, and qualification of PROVIREX’s cleanrooms…
Dr. Jan Chemnitz is a co-founder of PROVIREX. He has been one of the company’s managing directors since its founding and has driven its transition from a startup to a…
Oliver Ahnfeld is a co-founder of PROVIREX. He has been one of the CEOs of the company since its inception in 2019, and has focused on its entrepreneurial transformation into…
Dr. Jan Claas-von Jachmann has more than 25 years of experience in Biotech & Pharma industry covering a broad spectrum from Pre-clinical Research to Head of International Marketing and General…
Prof. Frank Buchholz is a co-founder of PROVIREX and professor for medical systems biology and Dean of Research at the medical faculty of the TU Dresden. He is a pioneer…